The Australasian Hepatology Association (AHA) is currently working with the Australian College of Nurse Practitioners (ACNP), the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), Burnet Institute, the Kirby Institute and NSW Health to develop greater transparency in Nurse Practitioner (NP) prescribing of Hepatitis C and Hepatitis B treatments. Accurate reporting is not currently possible from current PBS data sets.

The following 13 questions aim to comprehensively identify the breadth of NP prescribing of the hepatitis C and B treatments across Australia. The information obtained will contribute to, and inform, increased accuracy in reporting of NP prescribing of hepatitis C and hepatitis B treatments.

It is estimated the survey will take less than 5 minutes to complete.